NOVARTIS |
End-of-day quote
Other stock markets
|
||
| - GBX | - |
|
| 08:14am | NOVARTIS AG : Receives a Buy rating from Jefferies | ZD |
| Apr. 24 | BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating | MT |
Chart calendar NOVARTIS
dc8bb4449bc49e205d50e94532cadd.neJWHgpT7kc9yIjZjmdYDsdA_HHa-UZRYZodjCgpmWw.xaEBRj8evzRwi9m71hYbTYkQiyWCiAw7TPZQ-hhY0h3stBRnWBfZPWflzQ~dc3250045969a242057e80a1e98fe956
Upcoming events on NOVARTIS
Past events on NOVARTIS
| 2024-04-23 08:00 am | Q1 2024 Earnings Call |
| 2024-04-23 01:00 am | Q1 2024 Earnings Release |
| 2024-03-06 | Ex-dividend day for final dividend |
| 2024-03-04 | Annual General Meeting |
| 2024-03-02 | Muscular Dystrophy Association Clinical and Scientific Conference |
| 2024-01-31 08:00 am | Q4 2023 Earnings Call |
| 2024-01-31 01:00 am | Q4 2023 Earnings Release |
| 2024-01-08 11:35 am | JPMorgan Healthcare Conference |
| 2023-12-07 | San Antonio Breast Cancer Symposium |
| 2023-11-28 08:30 am | R&D Day |
| 2023-11-14 | Wolfe Research Healthcare Conference |
| 2023-11-14 | UBS European Conference |
| 2023-11-13 | Credit Suisse Healthcare Conference |
| 2023-11-13 10:30 am | Impact and Health Equity Conference |
| 2023-11-07 | UBS BioPharma Conference |
| 2023-10-24 08:00 am | Q3 2023 Earnings Call |
| 2023-10-24 07:00 am | ESMO Congress |
| 2023-10-24 01:00 am | Q3 2023 Earnings Release |
| 2023-10-23 11:10 am | ESMO Congress |
| 2023-10-03 | Spin off |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 47 445 47 897 -0.94% | 48 659 49 074 -0.85% | 51 626 51 902 -0.53% | 50 545 51 352 -1.57% | 45 440 46 810 -2.93% | 48 785 |
|
EBITDA Million USD | Released Forecast Spread | 15 809 15 640 1.08% | 16 845 16 496 2.12% | 18 246 18 336 -0.49% | 18 613 17 036 9.25% | 17 937 18 223 -1.57% | 19 290 |
|
EBIT Million USD | Released Forecast Spread | 14 112 14 152 -0.28% | 15 416 15 540 -0.8% | 16 588 16 712 -0.74% | 16 665 16 417 1.51% | 16 372 16 735 -2.17% | 18 126 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 8 940 9 963 -10.27% | 9 878 10 184 -3% | 26 137 18 886 38.39% | 8 371 10 562 -20.74% | 9 123 10 323 -11.63% | 12 843 |
|
Net income Million USD | Released Forecast Spread | 7 147 8 481 -15.73% | 8 072 8 392 -3.81% | 24 021 23 336 2.93% | 6 955 8 563 -18.78% | 14 854 10 329 43.8% | 10 372 |
|
EPS USD | Released Forecast Spread | 3,12 3,88 -19.63% | 3,55 3,68 -3.52% | 10,7 10,3 3.79% | 3,19 4,06 -21.46% | 7,15 5,38 32.95% | 5,06 |
| Announcement Date | 29/01/20 | 26/01/21 | 02/02/22 | 01/02/23 | 31/01/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 12 531 12 640 -0.86% | 12 781 12 767 0.11% | 12 543 12 737 -1.52% | 12 690 13 138 -3.41% | 12 953 12 567 3.07% | 13 622 13 270 2.65% | 11 782 11 373 3.6% | 11 423 11 773 -2.97% | 11 829 11 498 2.88% | 12 253 | 12 477 | 12 766 | 11 905 | 12 155 |
|
EBITDA Million USD | Released Forecast Spread | 4 407 4 039 9.12% | 4 989 | 4 783 3 239 47.69% | 4 473 4 104 8.99% | 4 668 | 4 224 4 775 -11.55% | ||||||||
|
EBIT Million USD | Released Forecast Spread | 4 083 4 092 -0.23% | 4 270 4 159 2.67% | 4 282 4 237 1.06% | 4 030 3 741 7.71% | 4 413 4 078 8.22% | 4 668 4 446 5% | 4 405 4 339 1.52% | 3 821 4 094 -6.66% | 4 537 4 220 7.52% | 4 588 | 4 697 | 4 542 | 4 790 | 4 895 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2 669 2 838 -5.95% | 2 042 2 548 -19.86% | 1 919 2 619 -26.73% | 1 741 2 521 -30.94% | 2 740 2 797 -2.04% | 2 769 3 194 -13.31% | 1 552 3 240 -52.1% | 2 377 3 495 -31.99% | 3 129 3 453 -9.38% | 3 856 | 3 880 | 3 665 | ||
|
Net income Million USD | Released Forecast Spread | 2 222 2 313 -3.93% | 1 695 2 340 -27.56% | 1 575 2 379 -33.79% | 1 466 2 919 -49.78% | 2 293 2 268 1.1% | 2 316 2 596 -10.8% | 1 513 2 786 -45.69% | 8 480 6 890 23.08% | 2 688 2 459 9.31% | 2 777 | 2 814 | 2 515 | ||
|
EPS USD | Released Forecast Spread | 1,00 1,04 -3.41% | 0,77 1,05 -26.4% | 0,73 1,17 -37.81% | 0,69 1,35 -48.9% | 1,09 1,07 1.82% | 1,11 1,26 -11.75% | 0,73 1,34 -45.68% | 4,14 2,87 44.31% | 1,31 1,19 10.18% | 1,36 | 1,39 | 1,25 | ||
| Announcement Date | 26/04/22 | 19/07/22 | 25/10/22 | 01/02/23 | 25/04/23 | 18/07/23 | 24/10/23 | 31/01/24 | 23/04/24 | - | - | - | - | - |
More events
Past sector events for NOVARTIS
- Stock Market
- Equities
- NOVN Stock
- 0HKE Stock
- Calendar NOVARTIS
